TET2 deficiency promotes MDS-associated leukemogenesis

Blood Cancer J. 2022 Oct 4;12(10):141. doi: 10.1038/s41408-022-00739-w.

Feiteng Huang^{1

2}, Jie Sun¹, Wei Chen³, Lei Zhang¹, Xin He¹, Haojie Dong¹, Yuhui Wu¹, Hanying Wang¹, Zheng Li¹, Brian Ball⁴, Samer Khaled⁴, Guido Marcucci^{1

4}, Ling Li⁵

¹ Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, 91010, USA.
² Department of Hematology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, China.
³ The Integrative Genomics Core, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, 91010, USA.
⁴ Department of Hematology and Hematopoietic Cell Transplantation (HCT), Beckman Research Institute, City of Hope Medical Center, Duarte, CA, 91010, USA.
⁵ Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, 91010, USA. [email protected].

No abstract available

Publication types